Sign In
Manage PermissionsManage Permissions

EIGHT Health Products Found Adulterated


The Ministry of Health would like to alert members of the public to eight (8) types of health products which have been tested by the Pharmacy Section, Department of Scientific Services, Ministry of Health and found to be adulterated with undeclared, potent western medicines.


The affected health products are listed as below:                                         

No.Name of productManufacturerAdulterated with

Ricalinu Kapsul


IP FarmaTramadol
2.Samulin KapsulSinar Jaya Makmur, IndonesiaAcetaminophen
3.Godong Ijo KapsulPJ. Air Madu, IndonesiaAcetaminophen, Dexamethasone,
4.Samyun Wan CapsuleNot Stated



5.Assalam Asam Urat & Flu Tulang KapsulPJ. Asli Sari Alam-Jabar, IndonesiaAcetaminophen
6.Lida Slimming Capsule 500mgPT Sinar Maju Makmur, IndonesiaSibutramine
7.Super X 500mg KapsulPJ. Husodo Jaya, IndonesiaSildenafil, Acetaminophen
8.Urat Kuda KapsulPJ. Kuda Mas, IndonesiaAcetaminophen


The adulterants found in these products can cause adverse effects that are potentially hazardous to the people using them.


Tramadol is used in management of acute pain. Its consumption without supervision can cause malaise, diarrhea, flatulence, gastric, anorexia, anxiety, difficulty in breathing, heart palpitations and syncope.


Acetaminophen or Paracetamol is a medicine that can be used for pain-relief and to reduce fever. Excessive Acetaminophen or Paracetamol use may lead to liver damage, kidney failure, coma and can result in death.

Unsupervised long-term consumption of potent corticosteroids such as Dexamethasone can cause increase blood glucose levels leading to diabetes, high blood pressure, cataracts, muscular and bone disorders, and an increased risk of infections. Long term use of corticosteroids can also lead to Cushing's syndrome which is characterized by a round face or 'moon face', and upper body obesity with thin limbs. Consumers who have taken high doses of steroids over a prolonged period of time may suffer from withdrawal symptoms which include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure and dehydration.

Cyproheptadine is antihistamines used in the treatment of allergies symptoms. If taken without supervision it can cause drowsiness, dizziness, muscle weakness, hypotension, blurred vision, dry mouth, depression, arrhythmias, increase in appetite and weight gain.


Sibutramine is a body slimming agent that is no longer recommended for its use in obesity treatment because its effects can be detrimental to the heart and the liver. Intake sibutramine can also cause serious adverse effects such as high blood pressure, uncertain heartbeat and difficulty sleeping; and regards the worst cases, it can cause damage to the kidneys and liver.


Sildenafil is a drug used to treat male impotency and can only be prescribed by a qualified doctor or physician. Among their side effects include nausea, vomiting, flushing and dizziness. In severe cases, they can also result in abnormal increase in heart rate, sudden loss of hearing and seizures.

The Ministry of Health has not issued any approval for the importation for the sale of these products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.


Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.


Members of the public involved in the retail of these products (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment.


The Ministry of Health would also like to call upon the public for their cooperation to report to the Compliance and Licensing Section if any of these products are still found on the market in this country.

For further information and communication, the public may contact the Compliance and Licensing Section at 2393298 extension 208; send an e-mail to; go directly to 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services' Building, Kg. Madaras, Mukim Gadong A; or call the Talian Darussalam 123.


- E N D -

Reference     : KK/PR/3

Date               : 12 March 2019 / 5 Rejab 1440H